Bridget S Wilkins

Summary

Affiliation: Guy's and St Thomas' NHS Foundation Trust
Country: UK

Publications

  1. doi request reprint Making the most of bone marrow trephine biopsy
    Bridget S Wilkins
    Guy s and St Thomas Hospitals NHS Foundation Trust, London, King s College, London and Newcastle University, Newcastle, UK
    Histopathology 55:631-40. 2009
  2. doi request reprint Pitfalls in bone marrow pathology: avoiding errors in bone marrow trephine biopsy diagnosis
    Bridget S Wilkins
    St Thomas Hospital and King s College, London, UK
    J Clin Pathol 64:380-6. 2011
  3. doi request reprint Pitfalls in lymphoma pathology: avoiding errors in diagnosis of lymphoid tissues
    Bridget S Wilkins
    Histopathology Department, Second Floor, North Wing, St Thomas Hospital and King s College, London SE1 7EH, UK
    J Clin Pathol 64:466-76. 2011
  4. pmc Resolution of bone marrow fibrosis in a patient receiving JAK1/JAK2 inhibitor treatment with ruxolitinib
    Bridget S Wilkins
    Haematologica 98:1872-6. 2013

Detail Information

Publications4

  1. doi request reprint Making the most of bone marrow trephine biopsy
    Bridget S Wilkins
    Guy s and St Thomas Hospitals NHS Foundation Trust, London, King s College, London and Newcastle University, Newcastle, UK
    Histopathology 55:631-40. 2009
    ....
  2. doi request reprint Pitfalls in bone marrow pathology: avoiding errors in bone marrow trephine biopsy diagnosis
    Bridget S Wilkins
    St Thomas Hospital and King s College, London, UK
    J Clin Pathol 64:380-6. 2011
    ..Final interpretation should be a synthesis of the histological findings with information from such haematological and other investigations, interpreted with due regard to clinical context...
  3. doi request reprint Pitfalls in lymphoma pathology: avoiding errors in diagnosis of lymphoid tissues
    Bridget S Wilkins
    Histopathology Department, Second Floor, North Wing, St Thomas Hospital and King s College, London SE1 7EH, UK
    J Clin Pathol 64:466-76. 2011
    ..Knowledge of such pitfalls, some of which are common while others are rare but of vital clinical importance, should help increase confidence in lymphoma diagnosis among histopathologists...
  4. pmc Resolution of bone marrow fibrosis in a patient receiving JAK1/JAK2 inhibitor treatment with ruxolitinib
    Bridget S Wilkins
    Haematologica 98:1872-6. 2013
    ..To our knowledge, this is the first detailed case report of resolution of fibrosis with a JAK1/JAK2 inhibitor. Trial registration: ClinicalTrials.gov Identifier: NCT00934544. ..